Total investments received (USD): 13.78m
Round value (USD): 2.37m
Round investors:
Capital Cell
Company: Ability Pharma


Belgium
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
United Kingdom